Our reviews

All our protocols and reviews are published online in the Cochrane Library.

Topics ranging from screening to chemotherapy and palliative radiotherapy

Full list:

By subtopic:

Diagnosis (1)
PET-CT (1)
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer
Staging (0)
Prevention (all lung cancer) (2)
Occupational protection (0)
Environmental protection (0)
Chemoprevention (1)
Drugs for preventing lung cancer in healthy people
Tobacco avoidance, including passive smoking (covered by the Tobacco Addiction Group) (0)
Others (1)
Non-invasive positive pressure ventilation for prevention of complications after pulmonary resection in lung cancer patients
Early detection (all lung cancer) (4)
Blood test (0)
Radiology (1)
Screening for lung cancer
Sputum Cytology (1)
Screening for lung cancer
Computerized Tomography (CT) (2)
Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality
Screening for lung cancer
Magnetic Resonance Imaging (MRI) (0)
Bronchoscopy (0)
Treatment (67)
NSCLC (44)
Immunotherapy (2)
Immunotherapy for non-small cell lung cancer in the elderly population: a generic protocol (protocol stage)
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer
Surgery (5)
Chemo-radiotherapy versus surgery-based treatment for Stage IIIA non-small cell lung cancer: a systematic review and network meta-analysis (protocol stage)
Preoperative exercise training for people with non-small cell lung cancer
Limited resections versus lobectomy for stage I non-small cell lung cancer (protocol stage)
Surgery for local and locally advanced non-small cell lung cancer
Video-assisted thoracoscopic lobectomy versus open thoracotomy conventional lobectomy for stage I non-small cell lung cancer (protocol stage)
Chemotherapy (18)
Gefitinib for advanced non-small cell lung cancer
Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status (protocol stage)
Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy-naive advanced non-small cell lung cancer
Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol (protocol stage)
Chemo-radiotherapy versus surgery-based treatment for Stage IIIA non-small cell lung cancer: a systematic review and network meta-analysis (protocol stage)
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer
Chemotherapy and supportive care versus supportive care alone for advanced non-small cell lung cancer
Chemotherapy for non-small cell lung cancer
Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer
Chemotherapy for advanced non-small cell lung cancer in the elderly population
First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer
Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) versus chemotherapy for second- or third-line treatment of metastatic non-small cell lung cancer (protocol stage)
Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: a generic protocol (protocol stage)
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer
Second-line chemotherapy for non-small cell lung cancer
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer
Taxanes for advanced non-small cell lung cancer (protocol stage)
Third-line systemic treatment for non-small cell lung cancer (protocol stage)
Radiotherapy (7)
Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol (protocol stage)
Chemo-radiotherapy versus surgery-based treatment for Stage IIIA non-small cell lung cancer: a systematic review and network meta-analysis (protocol stage)
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer
Palliative endobronchial brachytherapy for non-small cell lung cancer
Postoperative radiotherapy for non-small cell lung cancer
Stereotactic body radiation therapy versus more fractionated radical radiotherapy for adults with stage I/II non-small cell lung cancer: a systematic review and network meta-analysis (protocol stage)
Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small cell lung cancer
Combined modality therapy (10)
Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non-small-cell lung cancer and EGFR mutation (protocol stage)
Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol (protocol stage)
Concurrent chemoradiotherapy in non-small cell lung cancer
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent
Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors versus single agent chemotherapy as second-line treatment for non–small-cell lung cancer wild-type or unknown status for EGFR (protocol stage)
Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first-line treatment of advanced non-small cell lung cancer: a generic protocol (protocol stage)
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer
Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer
Chemotherapy and surgery versus surgery alone in non-small cell lung cancer
Therapeutic vaccines for advanced non-small cell lung cancer (protocol stage)
Holistic/complementary/non-invasive therapies (2)
Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer
Preoperative exercise training for people with non-small cell lung cancer
SCLC (11)
Surgery (1)
Surgery for limited-stage small-cell lung cancer
Chemotherapy (5)
Platinum versus non-platinum chemotherapy regimens for small cell lung cancer
Chemotherapy versus best supportive care for extensive small cell lung cancer
Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) plus platinum-etoposide versus platinum-etoposide alone for first-line treatment of extensive small cell lung cancer (protocol stage)
Chemotherapy for brain metastases from small cell lung cancer
Third-line systemic chemotherapy for small cell lung cancer (protocol stage)
Radiotherapy (4)
Altered fractionation of thoracic radiation therapy for localised small cell lung cancer (protocol stage)
Early versus late chest radiotherapy in patients with limited-stage small cell lung cancer
Prophylactic cranial irradiation for extensive-stage small cell lung cancer (protocol stage)
Prophylactic cranial irradiation for patients with limited-stage small cell lung cancer (protocol stage)
Combined modality therapy (0)
Holistic/complementary/non-invasive therapies (0)
immunotherapy (1)
Immune checkpoint inhibitors (anti PD-1 or anti PD-L1) plus platinum-etoposide versus platinum-etoposide alone for first-line treatment of extensive small cell lung cancer (protocol stage)
All lung cancer (7)
Surgery (2)
Gabapentinoids for chronic post-thoracotomy pain after lung surgery in adults (protocol stage)
Surgical sealant for preventing air leaks after pulmonary resections in patients with lung cancer
Chemotherapy (1)
Anti-angiogenic therapy for lung cancer (protocol stage)
Radiotherapy (0)
Combined modality therapy (1)
Interventions for smoking cessation in people diagnosed with lung cancer
Holistic/complementary/non-invasive therapies (3)
Exercise training for advanced lung cancer
Non-invasive interventions for improving well-being and quality of life in patients with lung cancer
Interventions for smoking cessation in people diagnosed with lung cancer
Mesothelioma (5)
Immunotherapy (0)
Surgery (0)
Chemotherapy (2)
Radical multimodality therapy for malignant pleural mesothelioma
Pemetrexed disodium in combination with cisplatin versus other cytotoxic agents or supportive care for the treatment of malignant pleural mesothelioma
Radiotherapy (3)
Radical multimodality therapy for malignant pleural mesothelioma
Radiation therapy for preventing instrumentation track metastases in malignant pleural mesothelioma (protocol stage)
Radiotherapy for malignant pleural mesothelioma

New and Updated (in the latest issue of the CLib):